About
Tadataka (Tachi) Yamada, MD, is the ard Chief Medical and Scientific Officer of Takeda Pharmaceuticals. In this capacity, he serves as a science and medical advisor to the CEO and chairs the Corporate Management Operating Committee, which oversees all investments in research and development, business development, and in-licensing. He is also the Senior Entrepreneur in Residence at Frazier Healthcare. In this role, he supports Frazier Healthcare’s venture and growth equity activities. Dr. Yamada was formerly the president of the Bill & Melinda Gates Foundation Global Health Program. Before joining the Gates Foundation, he was the chairman for research and development and a member of the board of directors for GlaxoSmithKline. Dr. Yamada was born in Japan and completed his education in the United States. He graduated from Stanford University with a bachelor of arts in history and obtained his doctor of medicine from the New York University School of Medicine. After completing his inte
Position in the VCSift Database
- • 3 investors at Frazier Healthcare Partners are tracked.
- • 1 investors hold the Venture Partner, Life Sciences Group role in VCSift. Tadataka Yamada is one of them.
- • 199 investors are based in Japan.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Japan
Contact Information
Find more investors like Tadataka
Search Investors